BIOS Fund II, LP, Director, 10% Owner at ACTUATE THERAPEUTICS, INC. (ACTU), sold 24,999 shares at $8.00 ($200K) on 2024-08-14, disclosed to the SEC on 2024-08-20.
Open-market sale of $200k ACTU by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 2,324 | $19K | 9.3% |
| 2 | $8.00 | 5,314 | $43K | 21.3% |
| 3 | $8.00 | 17,361 | $139K | 69.4% |
| Total | $8.00 avg | 24,999 | $200K | 100% |
| Filing → |
| INAB | BUY | 2022-08-17 | $6.7M | — | Filing → |